Normal view MARC view ISBD view

Drug design : structure- and ligand-based approaches / edited by Kenneth M. Merz, Dagmar Ringe, Charles H. Reynolds.

Contributor(s): Merz, Kenneth M, 1959- [editor.] | Ringe, Dagmar [editor.] | Reynolds, Charles H, 1957- [editor.] | Cambridge eBooks.
Publisher: Cambridge : Cambridge University Press, 2010Description: (x, 274 pages).Content type: text Media type: computer Carrier type: online resourceISBN: 9780521887236 (hardback).Subject(s): Drugs -- Design | Drugs -- Structure-activity relationshipsGenre/Form: Print books.
Contents:
1. Progress and issues for computationally guided lead discovery and optimization / William L. Jorgensen -- Part I. Structural biology: 2. X-ray crystallography in the service of structure-based drug design / Gregory A. Petsko and Dagmar Ringe -- 3. Fragment-based structure-guided drug discovery : strategy, process, and lessons from human protein kinases / Stephen K. Burley, Gavin Hirst, Paul Sprengeler, and Siegfried Reich -- 4. NMR in fragment-based drug discovery / Christopher A. Lepre, Peter J. Connolly, and Jonathan M. Moore -- Part II. Computational chemistry methodology: 5. Free energy calculations in structure-based drug design / Michael R. Shirts, David L. Mobley, and Scott P. Brown -- 6. Studies of drug resistance and the dynamic behavior of HIV-1 protease through molecular dynamics simulations / Fangyu Ding and Carlos Simmerling -- 7. Docking : a domesday report / Martha S. Head -- 8. The role of quantum mechanics in structure-based drug design / Kenneth M. Merz, Jr. -- 9. Pharmacophore methods / Steven L. Dixon -- 10. QSAR in drug discovery / Alexander Tropsha -- 11. Predicting ADME properties in drug discovery William J. Egan; Part III. Applications to drug discovery: 12. Computer-aided drug design : a practical guide to protein-structure-based modeling / Charles H. Reynolds -- 13. Structure-based drug design case study : p38 / Arthur M. Doweyko -- 14. Structure-based design of novel P2-P4 macrocyclic inhibitors of hepatitis / M. Katharine Holloway and Nigel J. Liverton -- 15. Purine nucleoside phosphorylases as targets for transition-state analogue design / Andrew S. Murkin and Vern L. Schramm -- 16. GPCR 3D modeling / Frank U. Axe -- 17. Structure-based design of potent glycogen phosphorylase inhibitors / Qiaolin Deng.
Summary: Structure-based (SBDD) and ligand-based (LBDD) drug design are extremely important and active areas of research in both the academic and commercial realms. This book provides a complete snapshot of the field of computer-aided drug design and associated experimental approaches. Topics covered include X-ray crystallography, NMR, fragment-based drug design, free energy methods, docking and scoring, linear-scaling quantum calculations, QSAR, pharmacophore methods, computational ADME-Tox, and drug discovery case studies. A variety of authors from academic and commercial institutions all over the world have contributed to this book, which is illustrated with more than 200 images. This is the only book to cover the subject of structure and ligand-based drug design, and it provides the most up-to-date information on a wide range of topics for the practising computational chemist, medicinal chemist, or structural biologist. Professor Kenneth Merz has been selected as the recipient of the 2010 ACS Award for Computers in Chemical & Pharmaceutical Research that recognizes the advances he has made in the use of quantum mechanics to solve biological and drug discovery problems.
    average rating: 0.0 (0 votes)

Title from publisher's bibliographic system (viewed on 05 Oct 2015).

1. Progress and issues for computationally guided lead discovery and optimization / William L. Jorgensen -- Part I. Structural biology: 2. X-ray crystallography in the service of structure-based drug design / Gregory A. Petsko and Dagmar Ringe -- 3. Fragment-based structure-guided drug discovery : strategy, process, and lessons from human protein kinases / Stephen K. Burley, Gavin Hirst, Paul Sprengeler, and Siegfried Reich -- 4. NMR in fragment-based drug discovery / Christopher A. Lepre, Peter J. Connolly, and Jonathan M. Moore -- Part II. Computational chemistry methodology: 5. Free energy calculations in structure-based drug design / Michael R. Shirts, David L. Mobley, and Scott P. Brown -- 6. Studies of drug resistance and the dynamic behavior of HIV-1 protease through molecular dynamics simulations / Fangyu Ding and Carlos Simmerling -- 7. Docking : a domesday report / Martha S. Head -- 8. The role of quantum mechanics in structure-based drug design / Kenneth M. Merz, Jr. -- 9. Pharmacophore methods / Steven L. Dixon -- 10. QSAR in drug discovery / Alexander Tropsha -- 11. Predicting ADME properties in drug discovery William J. Egan; Part III. Applications to drug discovery: 12. Computer-aided drug design : a practical guide to protein-structure-based modeling / Charles H. Reynolds -- 13. Structure-based drug design case study : p38 / Arthur M. Doweyko -- 14. Structure-based design of novel P2-P4 macrocyclic inhibitors of hepatitis / M. Katharine Holloway and Nigel J. Liverton -- 15. Purine nucleoside phosphorylases as targets for transition-state analogue design / Andrew S. Murkin and Vern L. Schramm -- 16. GPCR 3D modeling / Frank U. Axe -- 17. Structure-based design of potent glycogen phosphorylase inhibitors / Qiaolin Deng.

Structure-based (SBDD) and ligand-based (LBDD) drug design are extremely important and active areas of research in both the academic and commercial realms. This book provides a complete snapshot of the field of computer-aided drug design and associated experimental approaches. Topics covered include X-ray crystallography, NMR, fragment-based drug design, free energy methods, docking and scoring, linear-scaling quantum calculations, QSAR, pharmacophore methods, computational ADME-Tox, and drug discovery case studies. A variety of authors from academic and commercial institutions all over the world have contributed to this book, which is illustrated with more than 200 images. This is the only book to cover the subject of structure and ligand-based drug design, and it provides the most up-to-date information on a wide range of topics for the practising computational chemist, medicinal chemist, or structural biologist. Professor Kenneth Merz has been selected as the recipient of the 2010 ACS Award for Computers in Chemical & Pharmaceutical Research that recognizes the advances he has made in the use of quantum mechanics to solve biological and drug discovery problems.

Copyright © 2020 Alfaisal University Library. All Rights Reserved.
Tel: +966 11 2158948 Fax: +966 11 2157910 Email:
librarian@alfaisal.edu